BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8258339)

  • 21. Protection of CD3 delta knockout mice from lymphocytic choriomeningitis virus-induced immunopathology: implications for viral neuroinvasion.
    Kappes DJ; Lawrence DM; Vaughn MM; Davé VP; Belman AR; Rall GF
    Virology; 2000 Apr; 269(2):248-56. PubMed ID: 10753703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of protective cytotoxic T cells with viral proteins.
    Bachmann MF; Kündig TM; Freer G; Li Y; Kang CY; Bishop DH; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1994 Sep; 24(9):2228-36. PubMed ID: 8088338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of IL-12 on the response and susceptibility to experimental viral infections.
    Orange JS; Wolf SF; Biron CA
    J Immunol; 1994 Feb; 152(3):1253-64. PubMed ID: 7905500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination.
    Wille A; Gessner A; Lother H; Lehmann-Grube F
    Eur J Immunol; 1989 Jul; 19(7):1283-8. PubMed ID: 2503388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of treatment with IL-2 receptor specific monoclonal antibody in mice. Inhibition of cytotoxic T cell responses but not of T help.
    Leist TP; Kohler M; Eppler M; Zinkernagel RM
    J Immunol; 1989 Jul; 143(2):628-32. PubMed ID: 2544648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected].
    Planz O; Seiler P; Hengartner H; Zinkernagel RM
    Nature; 1996 Aug; 382(6593):726-9. PubMed ID: 8751445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro.
    Ehl S; Klenerman P; Aichele P; Hengartner H; Zinkernagel RM
    Eur J Immunol; 1997 Dec; 27(12):3404-13. PubMed ID: 9464829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abrogation of tolerance to a chronic viral infection.
    Jamieson BD; Somasundaram T; Ahmed R
    J Immunol; 1991 Nov; 147(10):3521-9. PubMed ID: 1940352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
    Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U
    J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHC class I and non-MHC-linked capacity for generating an anti-viral CTL response determines susceptibility to CTL exhaustion and establishment of virus persistence in mice.
    Moskophidis D; Lechner F; Hengartner H; Zinkernagel RM
    J Immunol; 1994 May; 152(10):4976-83. PubMed ID: 8176216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-12 is not required for induction of type 1 cytokine responses in viral infections.
    Oxenius A; Karrer U; Zinkernagel RM; Hengartner H
    J Immunol; 1999 Jan; 162(2):965-73. PubMed ID: 9916721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection.
    Seiler P; Aichele P; Odermatt B; Hengartner H; Zinkernagel RM; Schwendener RA
    Eur J Immunol; 1997 Oct; 27(10):2626-33. PubMed ID: 9368619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional heterogeneity of lymphocytic choriomeningitis virus-specfic T lymphocytes. I. Identification of effector amd memory subsets.
    Johnson ED; Cole GA
    J Exp Med; 1975 Apr; 141(4):866-81. PubMed ID: 47887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective antiviral cytotoxic T cell memory is most efficiently maintained by restimulation via dendritic cells.
    Ludewig B; Oehen S; Barchiesi F; Schwendener RA; Hengartner H; Zinkernagel RM
    J Immunol; 1999 Aug; 163(4):1839-44. PubMed ID: 10438917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus-specific cytotoxic T cell-mediated lysis of lymphocytes in vitro and in vivo.
    Kyburz D; Speiser DE; Aebischer T; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Jun; 150(11):5051-8. PubMed ID: 7684417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral T cells in mice lacking p56lck do not express significant antiviral effector functions.
    Molina TJ; Bachmann MF; Kündig TM; Zinkernagel RM; Mak TW
    J Immunol; 1993 Jul; 151(2):699-706. PubMed ID: 8393038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of antigen-specific tolerance by cyclosporin A.
    Stitz L
    Eur J Immunol; 1992 Aug; 22(8):1995-2001. PubMed ID: 1322301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and FcγR.
    Straub T; Schweier O; Bruns M; Nimmerjahn F; Waisman A; Pircher H
    Eur J Immunol; 2013 Sep; 43(9):2338-48. PubMed ID: 23749409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antivirally protective cytotoxic T cell memory to lymphocytic choriomeningitis virus is governed by persisting antigen.
    Oehen S; Waldner H; Kündig TM; Hengartner H; Zinkernagel RM
    J Exp Med; 1992 Nov; 176(5):1273-81. PubMed ID: 1402673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralizing antiviral antibodies reduce hematogenic viral spread but not antiviral cytotoxic T cell induction and subsequent immunopathology.
    Battegay M; Seiler P; Hunziker L; Wolf K; Zinkernagel RM
    J Infect Dis; 2001 May; 183(9):1425-7. PubMed ID: 11294679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.